Ads
related to: psoriasis
Search results
Everything You Need to Know About Getting Tape-In Extensions on Natural Hair
Allure via Yahoo News· 4 days agoBeyond having damaged hair, there are many reasons — health, hair length, lifestyle — why tape-in...
Nail Abnormalities: What to Know
Verywell Health via Yahoo News· 3 days agoCommon nail abnormalities, like spots, discoloration, and nail separation, can result from injuries to the fingers or other causes. Here’s what you need...
Apothecary in Superior offers natural remedies
Clark Fork Valley Press & Mineral Independent, Plains, Mont. via Yahoo News· 1 day agoMar. 27—The healing power of plants and the study of herbal medicine has become more popular in recent years at many people opt for Mother Nature's pharmaceutical drug store that has been used ...
Harvard Health Publishing And 3 Other Doctors Answer: What Is The Life Expectancy Of Someone With...
MSN News· 4 days agoAnswered by Dr. Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years of...
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
Zacks via Yahoo Finance· 4 days agoRenowned for serving science, Thermo Fisher Scientific TMO recently launched a new CorEvitas...
AbbVie to buy immune drug developer Landos
BioPharma Dive via Yahoo Finance· 4 days agoSanofi and Merck & Co. have also inked major deals for IBD treatments, while Takeda spent billions on a promising psoriasis medicine. Startups pursuing...
AbbVie (NYSE:ABBV) Trading Up 0.1% Following Analyst Upgrade
ETF DAILY NEWS· 9 hours agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0.1% on Wednesday after Barclays raised their price target on the stock from $185.00 to $195.00. AbbVie traded as high as $180.24 and last traded ...
Heavy-Duty Focus On Loss: Pharma Firms Spent $1.5B On Diabetes/Weight Ads
MediaPost· 2 days agoCelebrity use and news coverage -- perhaps best exemplified by last week’s ubiquitous Oprah Winfrey show, which gave pharma companies a ton of free exposure -- have helped drive the sale of ...
AbbVie (NYSE:ABBV) PT Raised to $195.00 at Barclays
ETF DAILY NEWS· 9 hours agoAbbVie (NYSE:ABBV – Get Free Report) had its price target increased by research analysts at Barclays from $185.00 to $195.00 in a research report issued on Wednesday, MarketBeat reports. Guggenheim ...
AnaptysBio, Inc. (NASDAQ:ANAB) CEO Daniel Faga Sells 145,940 Shares
ETF DAILY NEWS· 2 days agoAnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) CEO Daniel Faga sold 145,940 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average ...
Ads
related to: psoriasis